LEADER 01087nam0 22003011i 450 001 VAN0044763 005 20060503120000.0 010 $a88-8402-071-9 100 $a20060502d1991 |0itac50 ba 101 $aita 102 $aIT 105 $a|||| ||||| 200 1 $aMyricae$fGiovanni Pascoli$ga cura di Giuseppe Nava 205 $a2 ed. riv. e accresciuta 210 $aRoma$cSalerno$dstampa 1991 215 $aLXXVIII, 349 p.$d23 cm. 410 1$1001VAN0028373$12001 $aˆI ‰meridiani$1210 $aMilano$cMondadori. 620 $dRoma$3VANL000360 676 $a851.8$v21 700 1$aPascoli$bGiovanni$3VANV036082$0152621 702 1$aNava$bGiuseppe$3VANV036083 712 $aSalerno $3VANV108823$4650 801 $aIT$bSOL$c20221202$gRICA 899 $aBIBLIOTECA DEL DIPARTIMENTO DI LETTERE E BENI CULTURALI$1IT-CE0103$2VAN07 912 $aVAN0044763 950 $aBIBLIOTECA DEL DIPARTIMENTO DI LETTERE E BENI CULTURALI$d07CONS Zb Pascoli 1538 $e07 1599 20060502 996 $aMyricae$984737 997 $aUNISOB LEADER 08454nam 22007815 450 001 9910254486703321 005 20251117012414.0 010 $a3-319-48848-1 024 7 $a10.1007/978-3-319-48848-6 035 $a(CKB)4340000000223196 035 $a(DE-He213)978-3-319-48848-6 035 $a(MiAaPQ)EBC6311903 035 $a(MiAaPQ)EBC5610880 035 $a(Au-PeEL)EBL5610880 035 $a(OCoLC)1011496731 035 $a(PPN)221253769 035 $a(EXLCZ)994340000000223196 100 $a20171103d2017 u| 0 101 0 $aeng 135 $aurnn#008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aBreast Cancer $eInnovations in Research and Management /$fedited by Umberto Veronesi, Aron Goldhirsch, Paolo Veronesi, Oreste Davide Gentilini, Maria Cristina Leonardi 205 $a1st ed. 2017. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2017. 215 $a1 online resource (XIV, 928 p. 296 illus., 236 illus. in color.) 311 08$a3-030-12885-7 311 08$a3-319-48846-5 327 $aPart I An Integrated view of Breast Cancer Biology -- Fundamental pathways in breast cancer 1: signaling from the membrane -- Fundamental pathways in breast cancer 2: maintenance of genomic stability.-Fundamental pathways in breast cancer 3: estrogen biology -- Fundamental pathways in breast cancer 4: maintenance of epigenomic stability and the role of stem cells -- Breast cancer microenvironment and the metastatic process -- Mouse models of breast cancer -- Human mammary tumor virus proteins in human breast cancer cells -- Part II Epidemiology, Genetics and Prevention -- Epidemiology, life style and environment -- Genetic predisposition -- Chemoprevention -- Surgical prevention -- Part III Pathology: Standard and Molecular Diagnostics -- Premalignant lesions -- Prognostic and predictive role of genetic signatures -- Adding molecular information to immunohistochemistry -- Special types of breast cancer and nonepithelial tumors -- Pathology after neoadjuvant treatments -- Breast cancer genomics -- Pathology report 2015 -- Part IV Imaging -- Radiological screening of breast cancer. Evolution -- Innovation of radiological means for breast cancer -- Nuclear medicine in the clinical management (ROLL, SNB and PET) -- One-step systemic staging for patients with breast cancer -- Imaging after breast surgery -- Integrated breast biopsy for best radiological diagnosis of breast cancer -- Part V Oncological Surgery -- Conservative surgery -- Conservative mastectomies -- Surgical treatment of reappearance of breast cancer -- Management of the axilla -- Management of intraepithelial disease -- Surgery after neoadjuvant therapies -- Surgery of primary tumor in stage IV breast cancers -- Local therapy for breast cancer in malignant lymphoma survivors -- Surgery of metastases -- Part VI Plastic and Reconstructive Surgery -- Oncoplastic surgery -- Delayed breast reconstruction -- Immediate breast reconstruction direct-to-implant -- Breast reconstruction with tissue expanders and definitive implant replacement -- Breast reconstruction with pedicled flaps -- Breast reconstruction with free flaps -- Contralateral breast management -- Fat grafting in breast reconstruction -- Breast reconstruction with biological and nonbiological meshes -- How to manage complications in breast reconstruction -- Part VII Medical Oncology -- Adjuvant systemic therapies by subtypes: guidelines -- Primary systemic therapies: guidelines -- Treatment of advanced disease: guidelines -- Endocrine therapies in the adjuvant and advanced disease settings -- Chemotherapy regimens in the adjuvant and advanced disease settings -- Anti-HER2 therapies in the adjuvant and advanced disease settings -- Systemic therapy with bisphosphonates and anti-RANK-L agents -- Systemic treatment for specific medical situations -- Part VIII Radiotherapy -- Conceptual basis and principles of radiation oncology -- Whole breast radiation following breast-conserving surgery in invasive cancer -- Whole breast radiation following breast-conserving surgery in noninvasive cancer -- Post-mastectomy radiotherapy -- Integration of radiotherapy with systemic therapies -- Partial breast irradiation -- Intraoperative radiotherapy ELIOT -- Radiotherapy for metastatic lesions -- Part IX Special Conditions Requiring Multidisciplinary Approaches -- Emergencies in breast cancer -- Breast cancer during pregnancy -- Fertility issues in patients with newly diagnosed breast cancer -- Sexual functions and breast cancer -- Male breast cancer -- Inflammatory breast cancer -- Treatment of CNS involvement -- Treatment of skeletal disease -- Follow-up of patients with breast cancer -- Part X Investigating New Drugs and Immunological Agents in Breast Cancer -- Targeting immune-checkpoint -- Targeting PIK3CA/AKT/mTOR -- Targeting genome instability and DNA repair -- Targeting CDK4/6 pathway -- Targeting FGFR pathway -- Integrating next generation sequencing data in trial design -- Part XI Investigational and Miscellaneous Approaches -- Lifestyle and breast cancer -- Psychological support -- HIFU and radiofrequency as alternatives to surgery -- Hyperthermia with RT and with systemic therapies -- Electro-chemotherapy -- Circulating miRNA in early diagnosis -- Relevance of stem cells -- Part XII Biostatistics and Bioinformatics -- Subgroup analyses and information from clinical trials on breast cancer -- The methodology of meta analyses and its potential contribution to patient care -- Modern biostatistics for accelerated data acquisition for new drugs -- Bioinformatics for clinical use in breast cancer -- Efficacy endpoints in breast cancer studies. 330 $aThis book provides the reader with up-to-date information on important advances in the understanding of breast cancer and innovative approaches to its management. Current and emerging perspectives on genetics, biology, and prevention are first discussed in depth, and individual sections are then devoted to pathology, imaging, oncological surgery, plastic and reconstructive surgery, medical oncology, and radiotherapy. In each case the focus is on the most recent progress and/or state of the art therapies and techniques. Further topics to receive detailed consideration include particular conditions requiring multidisciplinary approaches, the investigation of new drugs and immunological agents, lifestyle and psychological aspects, and biostatistics and informatics. The book will be an excellent reference for practitioners, interns and residents in medical oncology, oncologic surgery, radiotherapy, pathology, and human genetics, researchers, and advanced medical students. 606 $aOncology 606 $aRadiology 606 $aSurgery 606 $aPathology 606 $aHuman genetics 606 $aBreast Neoplasms 606 $aBiomedical Research 606 $aOncology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33160 606 $aImaging / Radiology$3https://scigraph.springernature.com/ontologies/product-market-codes/H29005 606 $aSurgery$3https://scigraph.springernature.com/ontologies/product-market-codes/H59001 606 $aPathology$3https://scigraph.springernature.com/ontologies/product-market-codes/H4800X 606 $aHuman Genetics$3https://scigraph.springernature.com/ontologies/product-market-codes/B12008 615 0$aOncology. 615 0$aRadiology. 615 0$aSurgery. 615 0$aPathology. 615 0$aHuman genetics. 615 2$aBreast Neoplasms. 615 2$aBiomedical Research. 615 14$aOncology. 615 24$aImaging / Radiology. 615 24$aSurgery. 615 24$aPathology. 615 24$aHuman Genetics. 676 $a616.99449 702 $aVeronesi$b Umberto$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aGoldhirsch$b A$g(Aron),$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aVeronesi$b Paolo$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aGentilini$b Oreste Davide$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aLeonardi$b Maria Cristina$4edt$4http://id.loc.gov/vocabulary/relators/edt 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910254486703321 996 $aBreast Cancer$91521978 997 $aUNINA